| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |